Skip to main content
Have a personal or library account? Click to login
Tauopathies: A Distinct Class of Neurodegenerative Diseases Cover

Tauopathies: A Distinct Class of Neurodegenerative Diseases

Balkan Journal of Medical Genetics
Volume 10 (2007): Issue 2 (December 2007)
By:  and    
Open Access
|May 2008
References

References

  1. Hasegawa M, Smith MJ, Goedert M. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly.1998; 437(3): 207-210.
    Open DOISearch in Google Scholar
  2. Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wiederholt W, Hansen L, Masliah E, Thal LJ, Katzman R, Xia Y, Saitoh T. Genetic evidence for the involvement of tau in progressive supranuclear palsy.1997; 41(2): 277-281.
    Open DOISearch in Google Scholar
  3. Oliva R, Tolosa E, Ezquerra M, Molinuevo JL, Valldeoriola F, Burguera J, Calopa M, Villa M, Ballesta F. Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection.1998; 55(8): 1122-1124.
    Open DOISearch in Google Scholar
  4. Bennett P, Bonifati V, Bonuccelli U, Colosimo C, de Mari M, Fabbrini G, Marconi R, Meco, G, Nicholl DJ, Stocchi F, Vanacore N, Vieregge P, Williams AC. Direct genetic evidence for involvement of tau in progressive supranuclear palsy.1998; 51(4): 982-985.
    Open DOISearch in Google Scholar
  5. Morris HR, Janssen JC, Bandmann O, Daniel SR, Rossor, MN, Lees AJ, Wood NW. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases.1999; 66(5): 665-667.
    Open DOISearch in Google Scholar
  6. Higgins JJ, Golbe LI, de Biase A, Jankovic J, Factor SA, Adler RL. An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy.2000; 55(9): 1364-1367.
    Open DOISearch in Google Scholar
  7. Hoenicka J, Perez M, Perez-Tur J, Barabash A, Godoy M, Vidal L, Astarloa R, Avila J, Nygaard T, de Yebenes JG. The tau gene A0 allele and progressive supranuclear palsy.1999; 1(2): 1219-1225.
    Open DOISearch in Google Scholar
  8. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy.1999; 8(4): 711-715.
    Open DOISearch in Google Scholar
  9. Morris HR, Khan MN, Janssen JC, Brown JM, Perez-Tur J, Baker M, Ozansoy M, Hardy J, Hutton M, Wood NW, Lees AJ, Revesz T, Lantos P, Rossor MN. The genetic and pathological classification of familial frontotemporal dementia.2001; 58(11): 1813-1816.
    Open DOISearch in Google Scholar
  10. Houlden H, Baker M, Adamson J, Grover A, Waring S, Dickson D, Lynch T, Boeve B, Petersen RC, Pickering-Brown S, Owen F, Neary D, Craufurd D, Snowden J, Mann D, Hutton M. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia.1999; 46(2): 243-248.
    Open DOISearch in Google Scholar
  11. Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, George-Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bhatia KP, Dickson D, Wood NW, Hutton M. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype.2001; 56(12): 1702-1706.
    Open DOISearch in Google Scholar
  12. Conrad C, Vianna C, Freeman M, Davies P. Saitohin, a novel putative gene in the tau locus.2002; 99(11): 7751-7756.
    Open DOISearch in Google Scholar
  13. de Silva R, Hope A, Pittman A, Weale ME, Morris HR, Wood NW, Lees AJ. Strong association of the saitohin gene Q7 variant with progressive supranuclear palsy.2003; 61(3): 407-409.
    Open DOISearch in Google Scholar
  14. Russ C, Lovestone S, Baker M, Pickering-Brown SM, Andersen PM, Furlong R, Mann D, Powell JF. The extended haplotype of the microtubule associated protein tau gene is not associated with Pick's disease.2001; 299(1-2): 156-158.
    Open DOISearch in Google Scholar
  15. Morris HR, Baker M, Yasojima K, Houlden H, Khan MN, Wood NW, Hardy J, Grossman M, Trojanowski J, Revesz T, Bigio EH, Bergeron C, Janssen JC, McGeer PL, Rossor MN, Lees AJ, Lantos PL, Hutton M. Analysis of tau haplotypes in Pick's disease.2002; 59(3): 443-445.
    Open DOISearch in Google Scholar
  16. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N. Altered microtubule organization in small-calibre axons of mice lacking tau protein.1994; 369(6480): 488-491.
    Open DOISearch in Google Scholar
  17. Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.2001; 114(6): 1179-1187.
    Open DOISearch in Google Scholar
  18. Haltiwanger RS, Busby S, Grove K, Li S, Mason D, Medina L, Moloney D, Philipsberg G, Scartozzi R. O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to phosphorylation?.1997; 231(2): 237-242.
    Open DOISearch in Google Scholar
  19. Kreppel LK, Blomberg MA, Hart GW. Dynamic glycosylation of nuclear and cytosolic proteins.1997; 272(14): 9308-9315.
    Open DOISearch in Google Scholar
  20. Kamemura K, Hart GW. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription.2003; 73: 107-136.
    Open DOISearch in Google Scholar
  21. Dong DL, Xu ZS, Hart GW, Cleveland DW. Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H.1996; 271(34): 20845-20852.
    Open DOISearch in Google Scholar
  22. Lovestone S, Reynolds CH. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes.1997; 78(2): 309-324.
    Search in Google Scholar
  23. Seubert P, Mawal-Dewan M, Barbour R, Jakes R, Goedert M, Johnson GV, Litersky JM, Schenk D, Lieberburg L, Trojanowski JQ. Detection of phosphorylated Ser262 in fetal tau, adult tau and paired helical filament tau.1995; 270(32): 18917-18922.
    Open DOISearch in Google Scholar
  24. Goedert M, Hasegawa M, Jakes R, Lawler S, Cuenda A, Cohen P. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases.1997; 409(1): 57-62.
    Open DOISearch in Google Scholar
  25. Hayashi S, Toyoshima Y, Hasegawa M, Umeda Y, Wakabayashi K, Tokiguchi S, Iwatsubo T, Takahashi H. Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation.2002; 51(4): 525-530.
    Open DOISearch in Google Scholar
  26. Hasegawa M, Smith MJ, Iijima M, Tabira T, Goedert M. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10.1999; 443(2): 93-96.
    Open DOISearch in Google Scholar
  27. Jiang Z, Cote J, Kwon JM, Goate AM, Wu JY. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17.2000; 20(11): 4036-4048.
    Open DOISearch in Google Scholar
  28. Janssen JC, Warrington EK, Morris HR, Lantos P, Brown J, Revesz T, Wood N, Khan MN, Cipolotti L, Fox NC, Rossor MN. Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutation.2002; 58(8): 1161-1168.
    Open DOISearch in Google Scholar
  29. Hutton M. Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms.2001; 56(11 Suppl 4): S1-S25.
    Open DOISearch in Google Scholar
  30. Poorkaj P, Grossman M, Steinbart E, Payami H, Sdaovnick A, Nochlin D, Tabira T, Trojanowski JQ, Borson S, Galasko D, Reich S, Quinn B, Schellenberg G, Bird TD. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia.2001; 58(3): 383-387.
    Open DOISearch in Google Scholar
  31. Grover A, Houlden H, Baker M, Adamson J, Lewis J, Prihar G, Pickering-Brown S, Duff K, Hutton M. 5' Splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10.1999; 274(21): 15134-15143.
    Open DOISearch in Google Scholar
  32. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.1998; 95(13): 7737-7741.
    Open DOISearch in Google Scholar
  33. Varani L, Hasegawa M, Spillantini MG, Smith MJ, Murrell JR, Ghetti B, Klug A, Goedert M, Varani G. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17.1999; 96(14): 8229-8234.
    Open DOISearch in Google Scholar
  34. Spillantini MG, van Swieten JC, Goedert M,. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).2000; 2(4): 193-205.
    Open DOISearch in Google Scholar
  35. Yen S, Easson C, Nacharaju P, Hutton M, Yen SH. FTDP-17 tau mutations decrease the susceptibility of tau to calpain 1 digestion.1999; 461(1-2): 91-95.
    Open DOISearch in Google Scholar
  36. Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM. Rationalization of the effects of mutations on peptide and protein aggregation rates.2003; 424(6950): 805-808.
    Open DOISearch in Google Scholar
  37. Molinuevo JL, Valldeoriola F, Alegret M, Oliva R, Tolosa E. Progressive supranuclear palsy: earlier age of onset in patients with the ô protein A0/A0 genotype.2000; 247(3): 206-208.
    Open DOISearch in Google Scholar
  38. Stanford PM, Halliday GM, Brooks WS, Kwok JBJ, Storey CE, Creasey H, Morris JGL, Fulham MJ, Schofield PR. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene.2000; 123(5): 880-893.
    Open DOISearch in Google Scholar
  39. Rojo A, Pernaute RS, Fontan A, Ruiz PG, Honnorat J, Lynch T, Chin S, Gonzalo I, Rabano A, Martinez A, Daniel S, Pramsteller P, Morris H, Wood N, Lees A, Tabernero C, Nyggard T, Jackson AC, Hanson A, de Yébenes JG. Clinical genetics of familial progressive supranuclear palsy.1999; 122(7): 1233-1245.
    Open DOISearch in Google Scholar
  40. Higgins JJ, Rima L, Adler BA, Loveless JM. Mutational analysis of the tau gene in progressive supranuclear palsy.1999; 2(7): 1421-1424.
    Open DOISearch in Google Scholar
  41. Bergeron C, Davis A, Lang AE. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline.1998; 8(2): 355-365.
    Open DOISearch in Google Scholar
  42. Spillantini MG, Bird TD, Ghetti B. Fronto-temporal dementia and parkinsonism linked to chromosome 17: a new group of taupathies.1998; 8(2): 387-402.
    Open DOISearch in Google Scholar
  43. Buée L, Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease.1999; 9(4): 681-693.
    Open DOISearch in Google Scholar
  44. Virginia M, Lee Y, Trojanowski JQ. Neurodegenerative tauopathies: human disease and transgenic mouse models.1999; 24(3): 507-510.
    Open DOISearch in Google Scholar
  45. Heutink P. Untangling tau-related dementia.2000; 9(6): 979-986.
    Open DOISearch in Google Scholar
  46. Jaspert A, Fahsold R, Grehl H, Claus D. Myotonic dystrophy: correlation of clinical symptoms with the size of the CTG trinucleotide repeat.1995; 242(2): 99-104.
    Open DOISearch in Google Scholar
  47. Hof PR, Bouras C, Perl DP, Sparks DL, Mehta N, Morrison JH. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome.1995; 52(4): 379-391.
    Open DOISearch in Google Scholar
  48. Loftus SK, Morris JA, Carstea ED, Gu JZ, Cummings C, Brown A, Ellison J, Ohno K, Rosenfeld MA, Tagle DA, Pentchev PG, Pavan WJ. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene.1997; 277(5323): 232-235.
    Open DOISearch in Google Scholar
  49. Love S, Bridges LR, Case CP. Neurofibrillary tangles in Niemann-Pick disease type C.1995; 118(1): 119-129.
    Open DOISearch in Google Scholar
  50. Auer IA, Schmidt ML, Lee VMY, Curry B, Suzuki K, Shin RW, Pentchev PG, Carstea ED, Trojanowski JQ. Paired helical filament tau (PHF-tau) in Niemann-Pick tytpe C disease is similar to PHF-tau in Alzheimer's disease.1995; 90(6): 547-551.
    Open DOISearch in Google Scholar
  51. Sergeant N, Delacourte A, Buée L. Tau protein as a differential biomarker of tauopathies.2005; 1739(2-3): 179-197.
    Open DOISearch in Google Scholar
  52. Andreadis A, Wagner BK, Broderick JA, Kosik KS. A tau promoter region without neuronal specificity.1996; 66(6): 2257-2263.
    Open DOISearch in Google Scholar
  53. Heicklen-Klein A, Ginzburg I. Tau promoter confers neuronal specificity and binds Sp1 and AP-2.2000; 75(4): 1408-1418.
    Open DOISearch in Google Scholar
  54. Andreadis A, Brown WM, Kosik KS. Structure and novel exons of the human tau gene.1992; 31(43): 10626-10633.
    Open DOISearch in Google Scholar
  55. Rademakers R, Cruts M, van Broeckhoven C. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.2004; 24(4): 277-295.
    Open DOISearch in Google Scholar
  56. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human micro-tubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.1989; 3(4): 519-526.
    Open DOISearch in Google Scholar
  57. Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.1989; 8(2): 393-399.
    Open DOISearch in Google Scholar
  58. Brandt R, Leger J, Lee G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain.1995; 131(5): 1327-1340.
    Open DOISearch in Google Scholar
  59. Hirokawa N, Shiomura Y, Okabe S. Tau proteins: the molecular structure and mode of binding on microtubules.1988; 107(4): 1449-1459.
    Open DOISearch in Google Scholar
  60. Buée L, Bussiére T, Buée-Scherrer V, Delacourte A, Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders., 2000; 33(1): 95-130.
    Open DOISearch in Google Scholar
  61. Iqbal K, Alonso AC, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I. Tau pathology in Alzheimer disease and other tauopathies.2005; 1739(2-3): 198-210.
    Open DOISearch in Google Scholar
  62. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis.1992; 256(5054): 184-185.
    Open DOISearch in Google Scholar
  63. Buée-Scherrer V, Buée L, Leveugle D, Perl P, Vermesch P, Hof PR, Delacourte A. Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders.1997; 42(3): 356-359.
    Open DOISearch in Google Scholar
  64. Tolnay M, Probst A. The neuropathological spectrum of neurodegenerative tauopathies.2003; 55(6): 299-305.
    Open DOISearch in Google Scholar
  65. Albers DS, Augood SJ. New insights into progressive supranuclear palsy.2001; 24(6): 347-352.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10034-008-0001-5 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Journal RSS Feed
Language: English
Page range: 3 - 14
Published on: May 30, 2008
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
Tauopathies,
Neurodegeneration,
Tau gene,
Tau protein,
Tau mutations
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2008 M Ozansoy, A Başak, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.

Volume 10 (2007): Issue 2 (December 2007)
Next article